1. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Issue 9 (September 2021) Authors: Thijssen, Elisabeth H; La Joie, Renaud; Strom, Amelia; Fonseca, Corrina; Iaccarino, Leonardo; Wolf, Amy; Spina, Salvatore; Allen, Isabel E; Cobigo, Yann; Heuer, Hilary; VandeVrede, Lawren; Proctor, Nicholas K; Lago, Argentina Lario; Baker, Suzanne; Sivasankaran, Rajeev; Kieloch, Agnieszka; Kinhik... Journal: Lancet neurology Issue: Volume 20:Issue 9(2021) Page Start: 739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial. Issue 5 (9th April 2021) Authors: Kaul, Martin; End, Peter; Cabanski, Maciej; Schuhler, Carole; Jakab, Annamaria; Kistowska, Magdalena; Kinhikar, Arvind; Maiolica, Alessio; Sinn, Angela; Fuhr, Rainard; Cenni, Bruno Journal: Clinical and translational science Issue: Volume 14:Issue 5(2021) Page Start: 1756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗